Physical Activity for People With Behavioral Diagnoses

September 3, 2021 updated by: University of Oklahoma

The Physical and Psychosocial Influences of an Exercise and Activity Program on People With Behavioral Diagnoses: A Cohort Study

Our aims are to 1) test that our intervention that can be measured with high fidelity. 2) determine the feasibility of the intervention including recruitment, procedures, measures, intervention acceptability and resources . 3)We will also test the outcomes of this 14-week fitness and wellness program based at a YMCA Healthy Living Center to gauge the effects of exercise and activity on patients with behavioral diagnoses including bipolar disorder, schizoaffective disorder, and schizophrenia. We also want to explore the influence of participating in such a program on the perceptions of mental illness among rehabilitation sciences students.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Our aims are to 1) test that our intervention that can be measured with high fidelity. 2) determine the feasibility of the intervention including recruitment, procedures, measures, intervention acceptability and resources . 3)We will also test the outcomes of this 14-week fitness and wellness program based at a YMCA Healthy Living Center to gauge the effects of exercise and activity on patients with behavioral diagnoses including bipolar disorder, schizoaffective disorder, and schizophrenia. We also want to explore the influence of participating in such a program on the perceptions of mental illness among rehabilitation sciences students.

Our hypotheses are 1) that a fitness and activity program using physical activity, group discussion, and education delivered in a fitness facility will reduce anxiety and depression and strengthen hope, self-esteem, and improve overall quality of life; and 2) that student perceptions of mental illness will improve after participating in such a fitness and activity program.

Research Questions:

How does a program of exercise and activity influence the physical health of people with behavioural diagnoses as it relates to venous blood plasma measures of haemoglobin, cholesterol, lipids, insulin, glucose, triglycerides, high-density lipoproteins; height, weight, abdominal girth, blood pressure and heart rate; strength; and capacity for physical activity? How does a program of exercise and activity influence the psychosocial health of people with behavioural diagnoses as it relates to measures of hope, depression, anxiety, and self-esteem? How does a program of exercise and activity influence occupational performance and satisfaction of people with a behavioural diagnoses? How does a program of exercise and activity influence quality of life for people with a behavioral diagnoses ? How does participating in a program of exercise and activity influence the overall perceptions of people with behavioural diagnoses? What is the feasibility and fidelity of this 14-week intervention? How does being part of a program of exercise and activity for people with behavioural diagnoses influence perceptions of rehabilitation sciences students about mental illness?

EXPERIMENTAL DESIGN:

This follow up study involves a group of up to ten past participants recruited from patients being treated by the OU-Tulsa IMPACT Team. We will conduct interviews and baseline measures to compare to past progress. This study will serve to inform future cohorts for the original study protocol.

PROPOSED PROCEDURE:

Assessments include biophysical markers of health, self-reported psychosocial measures, and records of exercise and activity. Specifically, we will measure:

Cholesterol, lipids, and glucose/ A1C via blood specimens collected as a routine part of the patient's care Height and weight via stadiometer and digital scale, abdominal girth (the narrowest point between the xiphoid process and the navel) using a Gulick tape measure.

Blood pressure using a sphygmomanometer & heart rate by counting the pulse for 60 seconds using a digital timer Cardiovascular endurance via the three-minute step test Depression via the PHQ9 scale Anxiety using the Generalized Anxiety Disorder Test Interview/Focus Group Mental Illness Clinician Attitude Scale (MICA) This brief follow up study will assess participants who are one year out from the program or more. The study will take place in their residence and include the measures stated above and an interview. Researchers want to understand how the program is beneficial after one year and what can be improved to maintain benefits if any. Findings will be used to adjust the original protocol if needed to continue the original study. The assessments and interviews will be completed by researchers and occupational and physical therapy students under the supervision of their faculty. In addition, participants will be offered educational materials to help resume healthy habits.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oklahoma
      • Tulsa, Oklahoma, United States, 74135
        • University of Oklahoma Health Sciences Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

All study participants will be over the age of 21 and will include women and likely some individuals who report minority status with a mental health diagnosis

Exclusion Criteria:

Under the age of 21 or who are not psychologically stable in the last month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Single Group Pilot study pre/post
One group of 8 participants receiving 14 week intervention
Integrating Healthy Habits Optimized by Community Participation and Engagled Learning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Canadian Occupational Performance Measure
Time Frame: pre and post 14 week intervention
self-rating goal tool
pre and post 14 week intervention
Coach Fidelity Log Sheet
Time Frame: first 8 weeks
Coaches collected data for consistency of intervention
first 8 weeks
PHQ-9
Time Frame: week1 and week 14
self-rating depression screener
week1 and week 14
GAD
Time Frame: week1 and week 14
Self-rated anxiety scale
week1 and week 14

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Lipids
Time Frame: week1 and week 14
hemoglobin, cholesterol, lipids, insulin, glucose, triglycerides, high-density lipoproteins;
week1 and week 14

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2019

Primary Completion (Actual)

August 15, 2019

Study Completion (Actual)

December 16, 2019

Study Registration Dates

First Submitted

September 3, 2021

First Submitted That Met QC Criteria

September 3, 2021

First Posted (Actual)

September 13, 2021

Study Record Updates

Last Update Posted (Actual)

September 13, 2021

Last Update Submitted That Met QC Criteria

September 3, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9088

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Severe Mental Illness

Clinical Trials on IHOPE

Subscribe